Reference +375 17 287 10 01
operating mode: 8.00-17.30

Registry +375 17 287 10 70
operating mode: 8.00 – 15.40 (ПН.-Пт.)

e-mail: mail@oncology.by

Minsk R-n, d. Borovliany
43 Frunzenskaya street
location map

The science

The scientific Department of the Center organizes and coordinates all research work in the Center.

The scientific Department consists of an administrative and managerial staff and 6 laboratories:

  • clinical research;
  • molecular genetic research;
  • immunology;
  • cell biotechnology and herbal medicine;
  • genetic biotechnologies.

The Center currently has 3 doctors of medical Sciences and 29 candidates of science (11 candidates of biological Sciences and 18 candidates of medical Sciences). In addition, the research Department includes postgraduate and doctoral studies.

Postgraduate courses are open in the following specialties: Hematology and blood transfusion (since 1998), clinical immunology and Allergology (since 1998) and Oncology (since 2016). since 2016, the doctoral program has been opened: in the specialty of Hematology and blood transfusion, as well as in the specialty of Oncology. Over 20 years, 32 graduate students have been trained.

During the existence of the Center, 5 doctoral and 30 PhD theses were defended, and scientific titles were obtained:

  • corresponding member of the national Academy of Sciences of Belarus-1,
  • professors – 2,
  • associate Professor-13.

At the Moment, 15 people are studying in the center for postgraduate studies, and 8 people are studying in the doctoral program.

The main areas of scientific research are:

  • epidemiology of malignancies, immunodeficiency and hemopathies in children, adolescents and young adults;
  • development of a methodology for assessing and treating minimal residual disease in children and adolescents with malignancies;
  • development of programs for the treatment of malignant neoplasms and hematological diseases in children and adolescents using hematopoietic stem cell transplantation, hyperthermia and biotherapy;
  • development of graft cleaning methods and methods for treating graft-versus-host reactions;
  • development and experimental substantiation of immunological and molecular-biological bases of correction of primary (congenital) immunodeficiency States in children.
  • improvement of molecular genetic diagnostics of hereditary diseases, blood diseases, oncohematological diseases and primary immunodeficiency using third-generation sequencing (NGS) and bioinformatic analysis;
  • development of antitumor vaccination method, obtaining and testing of DNA vaccines;
  • development of cell immunotherapy, including natural killer cells (EK), as well as lymphocytes with a chimeric antigen receptor.